Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCMA CAR-T in Newly Diagnosed Multiple Myeloma
NCT05712083Phase 2Unknown
- Sponsor
- Zhejiang University
- Start
- Jan 2023
- Primary completion
- Apr 2024
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of BCMA CAR-T cells in multiple myeloma (MM), sponsored by Zhejiang University. Status: unknown.
02
Drugs
BCMA CAR-T cells
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT05712083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05712083.